Filter By Industry
Filter By Tag

Newsroom

Theralase Technologies Inc. Press releases

1 - 3 of 3 Press Releases

Mar 14, 2013
Toronto, ON -- March 14, 2013 -- Theralase Technologies Inc. (TSXV: TLT) announced that its proprietary Photo Dynamic Compound (PDC) technology has been approved for use in a live animal bladder cancer model by the University Health Network (UHN)...

Mar 28, 2012
Anti-cancer Photo Dynamic Compound (PDC) technology was found to completely destroy under the skin colon cancer tumours in a mouse model. Four weeks post treatment; the mice continue to be cancer free.

Mar 14, 2012
Pivotal Milestone Achieved – Theralase Advances Towards FDA Clinical Approval


Theralase Technologies Inc. RSS Feed